RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IMUC
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for ImmunoCellular Therapeutics Ltd stock price on Wednesday moving between $0.183 and $0.220
(Updated on Mar 27, 2024)

Sell candidate since Mar 26, 2024 Loss -20.43% PDF

The ImmunoCellular Therapeutics Ltd stock price fell by -20.43% on the last day (Wednesday, 27th Mar 2024) from $0.230 to $0.183. During the last trading day the stock fluctuated 20.22% from a day low at $0.183 to a day high of $0.220. The price has fallen in 6 of the last 10 days and is down by -36.9% for this period. Volume has increased on the last day by 31 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 38 thousand shares were bought and sold for approximately $6.98 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -39.69% during the next 3 months and, with a 90% probability hold a price between $0.0936 and $0.158 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IMUC Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The ImmunoCellular Therapeutics Ltd stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.232 and $0.258. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 13, 2024, and so far it has fallen -36.90%. Further fall is indicated until a new bottom pivot has been found. ImmunoCellular Therapeutics Ltd gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for ImmunoCellular Therapeutics Ltd stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0370 between high and low, or 20.22%. For the last week, the stock has had daily average volatility of 15.09%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IMUC) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect ImmunoCellular Therapeutics Ltd to open at $0.195, and during the day (based on 14 day Average True Range), to move between $0.134 and $0.232, which gives a possible trading interval of +/-$0.0489 (+/-26.74%) up or down from last closing price. If ImmunoCellular Therapeutics Ltd takes out the full calculated possible swing range there will be an estimated 53.48% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.192, some $0.0090 (4.92%) from the current price of $0.183, our system finds the risk reward not very attractive.

Is ImmunoCellular Therapeutics Ltd stock A Buy?

ImmunoCellular Therapeutics Ltd holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -8.185 Strong Sell Candidate Unchanged

Predicted Opening Price for ImmunoCellular Therapeutics Ltd of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$0.195 ( 6.74%) $0.183

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IMUC

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.232 26.96 %
R2 0.218 19.23 %
R1 0.209 14.46 %
Current price: 0.183
Support S1 0.181 -0.98 %
S2 0.172 -5.76 %
S3 0.158 -13.48 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.221 20.77 %
R2 0.220 20.22 %
R1 0.192 4.92 %
Current price 0.183
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for ImmunoCellular Therapeutics Ltd Stock and on which exchange is it traded?
The symbol for ImmunoCellular Therapeutics Ltd is IMUC and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell ImmunoCellular Therapeutics Ltd Stock?
ImmunoCellular Therapeutics Ltd holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy ImmunoCellular Therapeutics Ltd Stock?
ImmunoCellular Therapeutics Ltd Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ImmunoCellular Therapeutics Ltd Stock.

What's the current price of ImmunoCellular Therapeutics Ltd Stock?
As of the end of day on the 2024-03-27, the price of an ImmunoCellular Therapeutics Ltd (IMUC) share was $0.183.

What is the 52-week high and low for ImmunoCellular Therapeutics Ltd Stock?
The 52-week high for ImmunoCellular Therapeutics Ltd Stock is $0.400 and the 52-week low is $0.151.

What is the market capitalization of ImmunoCellular Therapeutics Ltd Stock?
As of the 2024-03-27, the market capitalization of ImmunoCellular Therapeutics Ltd is 20.729M.
Click to get the best stock tips daily for free!

About ImmunoCellular Therapeutics Ltd

ImmunoCellular Therapeutics  Ltd Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also dev... IMUC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT